When something goes wrong with an AI assistant, our instinct is to ask it directly: "What happened?" or "Why did you do that?

It's common for clinical-stage biotech companies to post net losses, but the market wasn't forgiving of this one's latest.

Company shares partnership and clinical updates including $7 million Sanofi milestone and more information on patient populations for REC-1245 (RBM39) and REC-617 (CDK7)SALT LAKE CITY, Aug. 05 ...

10 stocks we like better than Recursion Pharmaceuticals › Before market open on Tuesday, Recursion Pharmaceuticals (NASDAQ: RXRX) published its latest set of quarterly earnings and business update.

Florida python hunters Zach Hoffman, Jan Gianello and Justice Sargood caught a massive Burmese python in the Everglades on May 31, 2025.